Related Experiment Video
Updated: Aug 3, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide
D A Eppstein1, Y V Marsh, B B Schryver
1Cancer and Developmental Biology, Syntex Research, Palo Alto, California 94304.
Abstract:
Estrogen-stimulated growth of the human mammary adenocarcinoma cell line MCF-7 is significantly inhibited by monoclonal antibodies to the epidermal growth factor (EGF) receptor that act as antagonists of EGF's mitogenic events by competing for high-affinity EGF receptor binding sites. These antibodies likewise inhibit the EGF or transforming growth factor-alpha (TGF-alpha)-stimulated growth of these MCF-7 cells. An analogous pattern of specific EGF or TGF-alpha growth inhibitory activity was obtained using a synthetic peptide analog encompassing the third disulfide loop region of TGF-alpha, but containing additional modifications designed for increased membrane affinity [( Ac-D-hArg(Et)2(31),Gly32,33]HuTGF-alpha(31-43)NH2). The growth factor antagonism by this synthetic peptide was specific in that it inhibited EGF, TGF-alpha, or estrogen-stimulated growth of MCF-7 cells but did not inhibit insulin-like growth factor-1 (IGF-1)-stimulated cell growth. Altogether, these results suggest that a significant portion of the estrogen-stimulated growth of these MCF-7 cells is mediated in an autocrine/paracrine manner by release of EGF or TGF-alpha-like growth factors. The TGF-alpha peptide likewise inhibited EGF- but not fibroblast growth factor (FGF)- or platelet-derived growth factor (PDGF)-stimulated growth of NIH-3T3 cells in completely defined media; but had no effect on growth or DNA synthesis of G0-arrested cells, nor did it effect growth of NR-6 cells, which are nonresponsive to EGF. Although this synthetic peptide did not directly compete with EGF for cell surface receptor binding, it exhibited binding to a cell surface component (followed by internalization), which likewise was not competed by EGF. The peptide did not directly inhibit EGF-stimulated phosphorylation of the EGF receptor, nor did it inhibit phosphorylation of an exogenous substrate, angiotensin II, by activated EGF receptor. The TGF-alpha peptide did, however, affect the structure of laminin as manifested by laminin self-aggregation; this affect on laminin may, in turn, have a modulatory effect on EGF-mediated cell growth.
Insights
Monoclonal antibodies and a synthetic peptide targeting the epidermal growth factor (EGF) receptor inhibit estrogen-stimulated breast cancer cell growth, suggesting autocrine EGF/TGF-alpha signaling. These findings offer insights into growth factor roles in cancer.
Area of Science:
- * Molecular and Cellular Biology
- * Cancer Research
- * Endocrinology
Background:
- * Estrogen stimulates growth in human mammary adenocarcinoma MCF-7 cells.
- * Epidermal Growth Factor (EGF) receptor plays a role in cell proliferation.
- * Autocrine/paracrine signaling via growth factors is implicated in cancer progression.
Purpose of the Study:
- * To investigate the role of EGF receptor antagonists in inhibiting estrogen-stimulated MCF-7 cell growth.
- * To explore the mechanism of action of a synthetic TGF-alpha peptide analog.
- * To determine the involvement of autocrine EGF/TGF-alpha signaling in estrogen-mediated cell proliferation.
Main Methods:
- * Treatment of MCF-7 cells with monoclonal antibodies against the EGF receptor.
- * Administration of EGF, TGF-alpha, and a synthetic TGF-alpha peptide analog.
- * Assessment of cell growth inhibition and specificity using various growth factors (IGF-1, FGF, PDGF).
- * Investigation of peptide binding and effects on EGF receptor phosphorylation and laminin structure.
Main Results:
- * Monoclonal antibodies to the EGF receptor inhibited EGF, TGF-alpha, and estrogen-stimulated MCF-7 cell growth.
- * A synthetic TGF-alpha peptide analog specifically inhibited EGF, TGF-alpha, and estrogen-stimulated growth, but not IGF-1-stimulated growth.
- * The TGF-alpha peptide affected laminin structure, potentially modulating EGF-mediated cell growth.
- * The peptide bound to a cell surface component independently of EGF binding and did not directly inhibit EGF receptor phosphorylation.
Conclusions:
- * Estrogen-stimulated MCF-7 cell growth is significantly mediated by autocrine/paracrine EGF or TGF-alpha-like factors.
- * The synthetic TGF-alpha peptide acts as a specific growth factor antagonist.
- * The peptide's effect on laminin may represent a novel mechanism influencing cell growth signaling.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
10:23Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix
Published on: May 3, 2024
Related Concept Videos
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Clinical Applications of Epidermal Stem Cells